LBG
CLB icon

Lloyds Banking Group’s Core Laboratories CLB Stock Holding History

Lloyds Banking Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-60
Closed -$6K – 64
2017
Q2 		$6K Sell
60
-1,101
-95% -$119K 0.06% 58
2017
Q1 		$134K Sell
1,161
-142
-11% -$16.5K 1.21% 40
2016
Q4 		$156K Sell
1,303
-49
-4% -$5.42K 1.36% 37
2016
Q3 		$151K Sell
1,352
-51
-4% -$5.88K 1.36% 39
2016
Q2 		$173K Hold
1,403
– – 1.42% 36
2016
Q1 		$157K Buy
+1,403
New +$146K 1.28% 38
2014
Q2 		– Sell
-159,827
Closed -$31.7M – 534
2014
Q1 		$31.7M Sell
159,827
-11,460
-7% -$2.16M 0.28% 103
2013
Q4 		$32.7M Sell
171,287
-11,805
-6% -$2.2M 0.3% 89
2013
Q3 		$31M Sell
183,092
-18,409
-9% -$2.86M 0.32% 86
2013
Q2 		$30.6M Buy
+201,501
New +$28.6M 0.32% 81

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Lloyds Banking Group's CLB Position: Q3 2017 in Review

Lloyds Banking Group sold out of Core Laboratories (CLB) in Q3 2017, closing a stake of 60 shares — an estimated $6K sold.

Lloyds Banking Group first reported a position in CLB in Q2 2013 and held it in 10 quarters. The position peaked at $32.7M in Q4 2013. 345 funds tracked by Wall St. Rank hold CLB as of Q3 2017.

  • Lloyds Banking Group reported no remaining Core Laboratories position as of Q3 2017 after selling out during the quarter.
  • Lloyds Banking Group sold 60 Core Laboratories shares in Q3 2017, an estimated $6K.
  • Lloyds Banking Group first reported a position in Core Laboratories in Q2 2013 and held it in 10 quarters.
  • Lloyds Banking Group's Core Laboratories position peaked at $32.7M in Q4 2013.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2017.

Based on Lloyds Banking Group's 13F filing for Q3 2017, filed 3 Nov 2017.